By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Breaking US News – USA Business MediaBreaking US News – USA Business MediaBreaking US News – USA Business Media
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Font ResizerAa
Breaking US News – USA Business MediaBreaking US News – USA Business Media
Font ResizerAa
  • Home
  • USA
  • World
  • Business
  • Health
  • Sports
  • Cryptocurrency
  • Entertainment
  • Technology
Search
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Follow US
Home » Blog » Infosys grants ESOPs worth over ₹51 cr to CEO Salil Parekh
Business

Infosys grants ESOPs worth over ₹51 cr to CEO Salil Parekh

Olivia Roberts
By Olivia Roberts
Share
5 Min Read
SHARE

Salil Parekh, Executive Director of Infosys Ltd., speaks duration of a press conference in Bangalore, India, on Thursday, April 17, 2025.

Salil Parekh, Executive Director of Infosys Ltd., speaks duration of a press conference in Bangalore, India, on Thursday, April 17, 2025. | Photo credit: Karen days

The Second Board of Infosys of the IT company in India has approved the granting of actions of actions or options for employee actions (ESOPs) in ₹ 51 million rupees for the CEO and MD Salil Parekh.

The eldest of you yesterday declared its results Q4Fy25.

These stock incentives are under boxes of boxes, including ESG and equity.

In a recent archive, the company said the Board, based on the recommendations of the Nomination and Remuneration Committee, approved these annual subsidies to Parekh, according to its employment agreement appealed by the shareholders.

Among them is “Incentive subsidy of annual actions based on performance (annual performance capital subsidy) in the form of restricted shares units (RSU) that cover the company’s capital shares that have a market value of ₹ 34.75 million rupees as on the date of the subsidy under the 2015 shares incentive incentive plan (Plan 2015)”.

This, said Infosys, would grant 12 months from the subsidy date subject to the achievement of performance objectives as determined by the Board.

The NNT also includes the subsidy of annual shares incentives based on performance (annual performance of Capital of Performance) in the form of RSU that cover the capital shares of the company that have a market value of ₹ 2 million rupees on the date of the 2015 Plan subsidy, Whall The 2015, what the company’s achievement of certain milestones of environment, social and governance as determined by what is determined by the meeting.

It is also a green subsidy of the incentives of annual actions based on performance (annual performance of the RSU capital) that cover the capital shares of the company that have a market value of ₹ 5 million rupees on the date of the subsidy under the 2015 Plan. This will be granted from March 31, 2027 subject to certain criteria.

Infosys Also ReportoD that the nod includes: “The Grant of Annual Performance-Based Stock Incentives (2019 Annual Performance Equity Grant) in the form of restricted stock units (RSUS) Covering Company’s Equity Shares Having A Havet Value Infospescosy of ₹ Exdus Falos Falos of the Date Of The Date Of The Date Of The Date Of The ₹ ₹ ₹ The Date of the Date of ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ The Date of the date of ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹-₹-₹-₹-₹ S-₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹

The ESOPS will be granted with effect as of May 2, 2025, and the RSU number will be calculated based on the market price at the close of the negotiation of May 2, 2025, the company reported in a BS file on Thursday, since it launched the fourth quarter and the full yarecard.

Posted on April 18, 2025

Share This Article
Facebook Copy Link Print

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Rahul Yadav Indian Entrepreneur | India’s Mastermind of IT Innovation

In a time when technology reshapes every aspect of life and business,…

Apple’s ‘Friday Night Baseball’ is back on March 28 with a World Series documentary in tow

Apple's offered Major League Baseball games through the Apple TV app since…

10 Benefits of Forex Hedging Most Traders Don’t Know About

Hedging is possibly the most misunderstood trading method in the world. It's…

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

Business

India, Pakistan clash in Kashmir, shattering 2021 ceasefire pact

By Olivia Roberts
Business

Buzzing stocks: Infosys, Biocon, Royal Orchids, PVP Ventures, Rajesh Power, Spandana Sphoorty

By Olivia Roberts
Business

Two more independent directors resign from Gensol Engineering’s board

By Olivia Roberts
Business

Q4 Results Today Live Updates: Bajaj Housing Finance, Dalmia Bharat, Tamilnad Mercantile Bank, Tata Consumer Products & other 23 companies to announce Q4 results today, HCL Tech, AU Small Finance surges post Q4 results

By Olivia Roberts
Breaking US News – USA Business Media
USA
  • USA
  • World
  • Technology
  • Cryptocurrency
Business
  • CEO
  • Founder
  • Journalist
  • Entrepreneur
  • Technology
Health
  • Doctor
  • Beauty Cosmetics
  • Plastic Surgeon
Sports
  • Coach
  • Fitness Trainer
  • Entertainment

© 2017-2025 usabusinessmedia. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?